Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:46 PM
Ignite Modification Date:
2025-12-24 @ 5:46 PM
NCT ID:
NCT00939068
Eligibility Criteria:
Inclusion Criteria:
* 20-40 years old pregnant woman with gestational age of 20-32 week;
* positive serum HBsAg;
* HBV DNA≥1.0x106 copies/ml;
Exclusion Criteria:
* with previous antiviral treatment;
* with clinical sign of threatened miscarriage or related treatment in early pregnancy;
* positive serum HAV, HCV, HDV and HEV tests;
* fetus deformity by 3-D ultrasound examination;
* on other dugs, such as immune modulators, cytotoxic drugs or steroids;
* husbands are infected with HBV.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
20 Years
Maximum Age:
40 Years
Study:
NCT00939068
Study Brief:
Protocol Section:
NCT00939068